The landscape of treatment of blood cancers with FLT3 positive mutations by novel inhibitory therapeutics is massively growing, with many emerging and legacy companies venturing into the industry with their respective therapeutic portfolio exclusively developed and designed for the treatment of FLT3 mutated acute myeloid leukemia (AML). Through imaging, genetic, and biomarker studies, researchers are gaining a deeper understanding of the biology of AML, which will likely resolve many current problems in FLT3 mutated AML diagnosis and classification.

Equipment Type: Plastics laboratory ware (petri dishes, flasks, funnels, etc.) (excluding foam and wire coated) Industry: Other plastics product manufacturing

Report covers current market overview of the Rapid Microbiology Testing Market. Quantitative and Qualitative outlook. Global study focusing on the Europe, MEA, North America, Latin America and Asia Pacific. Country Level Information. Market Dynamics and Trends. Market Size and Forecast